½ÃÀ庸°í¼­
»óǰÄÚµå
1377889

¼¼°èÀÇ ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2023-2030)

Global Ultrasonic Nebulizers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 240 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ½ÃÀå ±Ô¸ð´Â 2022³â 2¾ï 1,079¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2023³âºÎÅÍ 2030³â±îÁö CAGR 6.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â ¾à 3¾ï 4,365¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú´Â ¾×ü ¾à¹°À̳ª ¿ë¾×À» ¹Ì¼¼ÇÑ ¾È°³³ª ¿¡¾î·ÎÁ¹·Î º¯È¯ÇÏ¿© Æó·Î ÈíÀÔÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ºÐ¹«±â´Â ÃÊÀ½ÆÄ Áøµ¿À» ÀÌ¿ëÇÏ¿© ¾×ü ¾à¹°À» ÈíÀÔÇϱ⠽±°í È£Èí±â¿¡ Èí¼öµÇ±â ½¬¿î 1-5¸¶ÀÌÅ©·Î¹ÌÅÍÀÇ ¹Ì¼¼ÇÑ ÀÔÀÚ·Î ºÐÇØÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ½ÃÀåÀº È£Èí±â Ä¡·á¿¡¼­ ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ Á߿伺À» °­Á¶ÇÏ´Â ¸î °¡Áö ÃËÁø¿äÀÎÀ¸·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀåÀ» °æÇèÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â õ½Ä, COPD, È£Èí±â °¨¿°°ú °°Àº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ È¿°úÀûÀÎ ÈíÀÔ ¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú´Â ¹Ì¼¼ÇÑ ¿¡¾î·ÎÁ¹ ¹æ¿ï ÇüÅ·ΠȿÀ²ÀûÀ̰í ÀϰüµÈ ¾à¹° Àü´ÞÀ» ÅëÇØ Á¤È®ÇÑ ¿ë·®ÀÌ Æó¿¡ µµ´ÞÇÒ ¼ö ÀÖµµ·Ï Çϱâ À§ÇØ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ºÐ¹«±â´Â »ç¿ëÇϱ⠽±°í ¸ðµç ¿¬·É´ëÀÇ È¯ÀÚ¿¡°Ô ÀûÇÕÇϱ⠶§¹®¿¡ ¸¹Àº °³Àΰú ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ¼±È£ÇÕ´Ï´Ù. ƯÈ÷ Àå½Ã°£ Ä¡·á ½Ã¿¡´Â Á¶¿ëÇÑ ÀÛµ¿ ¼Ò¸®·Î ÀÎÇØ ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ãŵ´Ï´Ù. ÈÞ´ë¿ë ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú¸¦ »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¸é¼­ ÁýÀ̳ª À̵¿ Áß¿¡µµ ½±°Ô Ä¡·áÇÒ ¼ö ÀÖ°Ô µÇ¾î Ä¡·á ¼øÀÀµµ°¡ ³ô¾ÆÁ³½À´Ï´Ù. ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ÇÔ²² È£Èí±â ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ºÐ¹«±â´Â ¸¸¼º ÁúȯÀ» °ü¸®ÇÏ´Â µ¥ Á¡Á¡ ´õ Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Çâ»óµÈ ¹èÅ͸® ¼ö¸í, È޴뼺, ½º¸¶Æ® ±â´É µî ºÐ¹«±â ¼³°èÀÇ ±â¼úÀû Áøº¸·Î ÀÎÇØ ºÐ¹«±â°¡ ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô ´õ¿í ¸Å·ÂÀûÀ¸·Î ´Ù°¡¿À°í ÀÖ½À´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼® ¹× ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¼¼°è ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú »ê¾÷ÀÇ ¼ºÀå°ú Ãß¼¼´ÂÀÌ ¿¬±¸¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

Áö¿ªºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä« ¹× Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú - »ê¾÷ ºÐ¼®

  • ¼­·Ð - ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • PorterÀÇ Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ½ÃÀå ºÐ¼® : »çÀÌÁ

  • °³¿ä : »çÀÌÁ
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : »çÀÌÁ
  • ¼Ò¿ë·®
  • ´ë¿ë·®

Á¦6Àå ¼¼°èÀÇ ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ¿ëµµº°
  • COPD
  • õ½Ä
  • ³¶Æ÷¼º ÅØ½ºÅ¸ÀÏÁõ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä : ÃÖÁ¾»ç¿ëÀÚº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ±â¾÷ÀÇ °æÀï ±¸µµ

  • ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ½ÃÀå °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ °³¿ä

  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Koninklijke Philips N.V
  • OMRON Healthcare Inc.
  • Drive Medical
  • Invacare Corporation
  • Medline Industries
  • Agilent Technologies Inc.
  • Inspired Medical
  • Mercury Medical
  • Besmed
  • AireHealth
LSH 23.11.23

The global demand for Ultrasonic Nebulizers Market is presumed to reach the market size of nearly USD 343.65 MN by 2030 from USD 210.79 MN in 2022 with a CAGR of 6.3% under the study period 2023 - 2030.

Ultrasonic nebulizers are medical devices used to convert liquid medications or solutions into fine mist or aerosol which is then inhaled into the lungs. These nebulizers employ ultrasonic vibrations to break down the liquid medication into tiny particles, typically ranging in size from 1 to 5 micrometers, which are easy to inhale and get absorbed by the respiratory system.

MARKET DYNAMICS:

The Ultrasonic nebulizers market is experiencing robust growth due to several driving factors that underscore the significance of these devices in respiratory care. Key drivers include the increasing prevalence of respiratory conditions like asthma, COPD, and respiratory infections, leading to a higher demand for effective inhalation therapy. Ultrasonic nebulizers are sought after for their efficient and consistent medication delivery in the form of fine aerosol droplets, ensuring precise dosages reach the lungs. These nebulizers are user-friendly and suitable for patients of all ages, making them a preferred choice for many individuals and healthcare providers. Their quiet operation enhances patient comfort, especially during longer treatment sessions. The availability of portable ultrasonic nebulizers is facilitating treatment at home or on the go, improving therapy adherence. As the global population ages, the prevalence of respiratory conditions rises, and nebulizers become increasingly vital for chronic disease management. Furthermore, technological advancements in nebulizer design, such as enhanced battery life, portability, and smart features, are making these devices more appealing to patients and healthcare providers.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ultrasonic nebulizers. The growth and trends of ultrasonic nebulizers industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the ultrasonic nebulizers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Size

  • Small-Volume
  • Large-Volume

By Application

  • COPD
  • Asthma
  • Cystic Fibrosis
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Ultrasonic Nebulizers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Ultrasonic Nebulizers market include Koninklijke Philips N.V, OMRON Healthcare, Inc., Drive Medical, Invacare Corporation, Medline Industries, Agilent Technologies, Inc., Inspired Medical, Mercury Medical, Besmed, AireHealth. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ULTRASONIC NEBULIZERS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Size
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ULTRASONIC NEBULIZERS MARKET ANALYSIS BY SIZE

  • 5.1 Overview by Size
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Size
  • 5.4 Small-Volume Historic and Forecast Sales by Regions
  • 5.5 Large-Volume Historic and Forecast Sales by Regions

6 . GLOBAL ULTRASONIC NEBULIZERS MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 COPD Historic and Forecast Sales by Regions
  • 6.5 Asthma Historic and Forecast Sales by Regions
  • 6.6 Cystic Fibrosis Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL ULTRASONIC NEBULIZERS MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-User
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-User
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Specialty Clinics Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ULTRASONIC NEBULIZERS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ULTRASONIC NEBULIZERS COMPANIES

  • 9.1. Ultrasonic Nebulizers Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ULTRASONIC NEBULIZERS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Koninklijke Philips N.V
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. OMRON Healthcare Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Drive Medical
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Invacare Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Medline Industries
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Agilent Technologies Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Inspired Medical
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Mercury Medical
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Besmed
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. AireHealth
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦